Fisher & Paykel Healthcare 미래 성장

Future 기준 확인 4/6

Fisher & Paykel Healthcare (는) 각각 연간 21.2% 및 10.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 20.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 23.8% 로 예상됩니다.

주요 정보

21.2%

수익 성장률

20.71%

EPS 성장률

Medical Equipment 수익 성장	18.1%
매출 성장률	10.9%
향후 자기자본 수익률	23.82%
애널리스트 커버리지	Good
마지막 업데이트	22 May 2025

최근 미래 성장 업데이트

Recent updates

Unpleasant Surprises Could Be In Store For Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares

Mar 25

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Feb 22

Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Paint A Concerning Picture

Feb 07

There May Be Some Bright Spots In Fisher & Paykel Healthcare's (NZSE:FPH) Earnings

Dec 05

New Product Launches And Capacity Expansion Fuel Optimism Amid Margin Pressure And Growth Uncertainty

Dec 01 Diversification with new products and increased manufacturing capacity may drive revenue, but risks include overestimating demand and resulting profit margin pressures.

The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Oct 28

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon

Oct 08

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Aug 21

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jul 29

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Jul 11

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Jun 22

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Jun 05

수익 및 매출 성장 예측

NZSE:FPH - 애널리스트의 미래 추정치 및 과거 재무 데이터 (NZD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2028	2,882	622	459	693	4
3/31/2027	2,556	517	396	616	14
3/31/2026	2,282	427	302	530	15
3/31/2025	2,008	359	348	468	15
9/30/2024	1,890	179	388	506	N/A
6/30/2024	1,817	156	239	468	N/A
3/31/2024	1,743	133	91	430	N/A
12/31/2023	1,719	197	61	411	N/A
9/30/2023	1,694	262	31	393	N/A
6/30/2023	1,638	256	29	316	N/A
3/31/2023	1,581	250	27	238	N/A
12/31/2022	1,527	251	6	218	N/A
9/30/2022	1,472	251	-15	199	N/A
6/30/2022	1,577	314	70	262	N/A
3/31/2022	1,682	377	155	324	N/A
12/31/2021	1,821	449	259	430	N/A
9/30/2021	1,961	521	363	535	N/A
6/30/2021	1,966	522	402	580	N/A
3/31/2021	1,971	524	441	625	N/A
12/31/2020	1,787	458	344	526	N/A
9/30/2020	1,603	392	247	426	N/A
6/30/2020	1,433	339	199	374	N/A
3/31/2020	1,264	287	151	321	N/A
12/31/2019	1,197	260	133	297	N/A
9/30/2019	1,130	233	115	273	N/A
6/30/2019	1,100	221	117	263	N/A
3/31/2019	1,070	209	120	253	N/A
12/31/2018	1,052	208	135	256	N/A
9/30/2018	1,034	206	151	259	N/A
6/30/2018	1,007	198	N/A	253	N/A
3/31/2018	981	190	N/A	248	N/A
12/31/2017	954	181	N/A	224	N/A
9/30/2017	928	172	N/A	200	N/A
6/30/2017	911	171	N/A	197	N/A
3/31/2017	894	169	N/A	194	N/A
12/31/2016	877	164	N/A	190	N/A
9/30/2016	860	160	N/A	186	N/A
6/30/2016	838	152	N/A	165	N/A
3/31/2016	815	143	N/A	145	N/A
12/31/2015	776	135	N/A	135	N/A
9/30/2015	736	126	N/A	126	N/A
6/30/2015	704	120	N/A	136	N/A
3/31/2015	672	113	N/A	147	N/A
12/31/2014	655	107	N/A	134	N/A
9/30/2014	637	101	N/A	122	N/A
6/30/2014	630	99	N/A	111	N/A

애널리스트 미래 성장 예측

수입 대 저축률: FPH 의 연간 예상 수익 증가율( 21.2% )이 saving rate( 3.4% 보다 높습니다. ).

수익 vs 시장: FPH 의 연간 수익( 21.2% ) NZ 시장( 23.8% 보다 느리게 성장할 것으로 예상됩니다. 23.8% 연간).

고성장 수익: FPH 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: FPH 의 수익(연간 10.9% ) NZ 시장( 4.6% 보다 빠르게 성장할 것으로 예상됩니다. 4.6% 연간).

고성장 수익: FPH 의 수익(연간 10.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: FPH 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 23.8 %)

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/05/23 11:21
장 마감 주가	2025/05/23 00:00
수익	2024/09/30
연간 수익	2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Fisher & Paykel Healthcare Corporation Limited 27 애널리스트 중 15 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Saul Hadassin	Barrenjoey Markets Pty Limited
Lyanne Harrison	BofA Global Research
Mathieu Chevrier	Citigroup Inc

Fisher & Paykel Healthcare 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 7.3% to NZ$33.45

Price target increased by 7.3% to NZ$27.77

Price target increased by 7.0% to NZ$23.63

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of 2024

Consensus EPS estimates fall by 14%

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2024

Recent updates

Unpleasant Surprises Could Be In Store For Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares

Fisher & Paykel Healthcare Launches F&P Nova Nasal Mask in New Zealand and Australia

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Fisher & Paykel Healthcare Corporation Limited to Report Q2, 2026 Results on Nov 26, 2025

Fisher & Paykel Healthcare Corporation Limited to Report Q2, 2026 Results on Sep 30, 2025

Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Paint A Concerning Picture

Price target increased by 7.3% to NZ$33.45

There May Be Some Bright Spots In Fisher & Paykel Healthcare's (NZSE:FPH) Earnings

New Product Launches And Capacity Expansion Fuel Optimism Amid Margin Pressure And Growth Uncertainty

First half dividend of NZ$0.22 announced

First half 2025 earnings: EPS misses analyst expectations

Fisher & Paykel Healthcare Corporation Limited Approves Interim Dividend for the Six Months to 30 September 2024, Payable on 18 December 2024

The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2025 Results on Nov 28, 2024

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon

Insider recently sold NZ$1.3m worth of stock

MD, CEO & Executive Director recently sold NZ$1.8m worth of stock

Price target increased by 7.3% to NZ$27.77

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Fisher & Paykel Healthcare Corporation Limited Announces Board and Committee Changes

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Upcoming dividend of NZ$0.28 per share

Fisher & Paykel Healthcare Corporation Limited, Annual General Meeting, Aug 28, 2024

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Final dividend of NZ$0.28 announced

Full year 2024 earnings: EPS misses analyst expectations

Price target increased by 7.0% to NZ$23.63

Fisher & Paykel Healthcare Corporation Limited to Report Fiscal Year 2024 Results on May 29, 2024

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

First half 2024 earnings: EPS exceeds analyst expectations

Fisher & Paykel Healthcare Corporation Limited Approves Interim Dividend, Payable on 18 December 2023

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2024 Results on Nov 29, 2023

Fisher & Paykel Healthcare Corporation Limited Announces Launch of F&P Solo Mask in New Zealand and Australia for Treatment of Obstructive Sleep Apnea

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of 2024

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Upcoming dividend of NZ$0.27 per share at 1.6% yield

Fisher & Paykel Healthcare Corporation Limited, Annual General Meeting, Aug 29, 2023

Consensus EPS estimates fall by 14%

Full year 2023 earnings released: EPS: NZ$0.43 (vs NZ$0.65 in FY 2022)

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2024

Vice President of Products & Technology exercised options to buy NZ$194k worth of stock.

Price target increased by 7.4% to NZ$23.89

Consensus EPS estimates increase by 11%

Fisher & Paykel Healthcare Corporation Limited Provides Revenue Guidance for the Financial Year Ending 31 March 2023

Price target increased to NZ$22.88

Price target increased to NZ$22.79

Investor sentiment improved over the past week

First half 2023 earnings: EPS and revenues exceed analyst expectations

Fisher & Paykel Healthcare Corporation Limited Announces Ordinary Distribution for the Six Months Ended September 30, 2022, Payable on December 21, 2022

Independent Non-Executive Director recently bought NZ$58k worth of stock

Independent Non-Executive Director recently bought NZ$108k worth of stock

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2023 Results on Nov 29, 2022

Price target decreased to NZ$21.30

Consensus EPS estimates fall by 29%

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of Fiscal Year 2023

Fisher & Paykel Healthcare Announces Management Changes

Fisher & Paykel Healthcare Corporation Limited Declares Ordinary Dividend for the Six Months Period Ended March 31, 2022, Payable on July 6, 2022

Upcoming dividend of NZ$0.26 per share

Consensus EPS estimates fall by 15%

Fisher & Paykel Healthcare Corporation Limited Appoints Cather Simpson as Non-Executive Director, Effect 1 June 2022

Price target decreased to NZ$23.98

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Fisher & Paykel Healthcare Corporation Limited Approves Final Dividend, Payable on 6 July 2022

Insufficient new directors

Investor sentiment deteriorated over the past week